Alvotech
Latest news
Investors
17 March 2023
Alvotech to Present Clinical Study Data for AVT04, a Proposed Biosimilar to Stelara®, at 2023 American Academy of Dermatology (AAD) Annual Meeting
Investors
01 March 2023
Alvotech Reports Financial Results for Full Year 2022 and Provides Business Update
Investors
28 February 2023